190 related articles for article (PubMed ID: 20010554)
1. The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making.
Brass EP
Clin Pharmacol Ther; 2010 Mar; 87(3):351-5. PubMed ID: 20010554
[No Abstract] [Full Text] [Related]
2. Note on special technical issue on adaptive designs for clinical trials.
Liu Q; Chang M
J Biopharm Stat; 2012; 22(4):615-6. PubMed ID: 22651104
[No Abstract] [Full Text] [Related]
3. Disease models.
Gobburu J
Clin Adv Hematol Oncol; 2008 Apr; 6(4):241-2. PubMed ID: 18496490
[No Abstract] [Full Text] [Related]
4. Similarity trials.
Nat Biotechnol; 2011 Jan; 29(1):1. PubMed ID: 21221076
[No Abstract] [Full Text] [Related]
5. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
[TBL] [Abstract][Full Text] [Related]
6. Status of the GCP guidelines in Europe.
Geussenhainer S
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice guidelines to improve shared decision-making about assistive device use in home care: a pilot intervention study.
Roelands M; Van Oost P; Stevens V; Depoorter A; Buysse A
Patient Educ Couns; 2004 Nov; 55(2):252-64. PubMed ID: 15530763
[TBL] [Abstract][Full Text] [Related]
8. [The inspection by the Danish Medical Products Agency of drug clinical trials].
Jacobsen E; Stilbo I
Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
[TBL] [Abstract][Full Text] [Related]
9. They are from the government and they really are here to help you.
Woosley RL
J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
[No Abstract] [Full Text] [Related]
10. Clinical trial design issues in schizophrenic research.
Casey DE
J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
[TBL] [Abstract][Full Text] [Related]
11. Communicating with the FDA: the "third rail" of a new model for drug development.
Stanski DR; Orloff JJ
J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
[No Abstract] [Full Text] [Related]
12. Hotel-based rheumatology, and more.
Leeb BF
J Rheumatol; 2009 Feb; 36(2):455-6; author reply 456-7. PubMed ID: 19208582
[No Abstract] [Full Text] [Related]
13. Dosing strategies for antidepressant clinical trials: a commentary.
Robinson DS; Khan A
J Clin Psychopharmacol; 2004 Feb; 24(1):1-3. PubMed ID: 14709939
[No Abstract] [Full Text] [Related]
14. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
Bottomley A; Jones D; Claassens L
Eur J Cancer; 2009 Feb; 45(3):347-53. PubMed ID: 19013787
[TBL] [Abstract][Full Text] [Related]
15. Good Publication Practice guidelines for clinical trials?
Alfaro V
Clin Pharmacol Ther; 2003 Jul; 74(1):97-8. PubMed ID: 12844142
[No Abstract] [Full Text] [Related]
16. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
Ichimaru K; Toyoshima S; Uyama Y
Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
[No Abstract] [Full Text] [Related]
17. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
18. Making changes in clinical trials.
Weaver WD; Greenberg S
Am Heart J; 2001 Feb; 141(2):295-300. PubMed ID: 11174346
[No Abstract] [Full Text] [Related]
19. Guidelines--are they useful?
Ben-Menachem E; French JA
Epilepsia; 2006; 47 Suppl 1():62-4. PubMed ID: 17044829
[TBL] [Abstract][Full Text] [Related]
20. Errors in 'Trials and error'.
Miller DD
Nat Biotechnol; 2006 Jul; 24(7):747. PubMed ID: 16841048
[No Abstract] [Full Text] [Related]
[Next] [New Search]